Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to Indiana University/Melvin and Bren Simon Cancer Center · Indianapolis, Indiana
Answer a few short questions to share with the research team.